00:01
Now let's talk about
progressive supranuclear palsy.
00:05
PSP is a degenerative
movement disorder
that affects the brainstem,
basal ganglia, diencephalon,
and in some cases,
the cortex causing gaze dysfunction,
extrapyramidal symptoms
and cognitive dysfunction.
00:19
And that's really important.
00:20
I want to highlight a few
key features with PSP.
00:23
One is the diencephalon
dysfunction.
00:26
And this contributes to early
vertical gaze palsy, gaze dysfunction
which is one of the things we
look forward to differentiate PSP
from other Parkinson's and
Parkinsonian syndromes.
00:37
What brain areas
are involved in PSP?
Well, here we're thinking
about the midbrain.
00:42
The brainstem can be involved but
prominent diencephalon involvement,
and upper midbrain involvement is a key
feature of progressive supranuclear palsy.
00:54
Like other neurodegenerative
conditions,
it results from progressive
deposition of an abnormal protein
and PSP is a tauopathy.
01:04
So we can think of the other
tauopathies and this acts similarly.
01:08
We define the tauopathies or we remember
the tauopathies by that mnemonic APCP-
Alzheimer's disease,
progressive supranuclear palsy,
corticobasal degeneration and what
was previously called Pick's disease
or frontotemporal dementia.
01:23
In this condition, we see
hyper-phosphorylation of the tau protein
leading to reduced affinity
for the microtubules.
01:31
Hyper-phosphorylation of tau
is resistant to proteolysis
and forms neurofibrillary
tangles aggregates of tau
which leads to
neuronal dysfunction.
01:42
What about the clinical
manifestations in PSP?
This is typically insidious in
onset and relentlessly progressive
like all of the Parkinson's-plus syndromes,
it's a neurodegenerative syndrome.
01:53
Symptoms start and they
progressed gradually
and progressively and
relentlessly over time.
01:59
Patients also present with a prominent
akinetic-rigid form of parkinsonism.
02:05
So we can think about
tremor-dominant parkinsonism
where patients have
prominent tremor
or akinetic-rigid
forms of parkinsonism
where there's a reduction in movement
and prominent axial rigidity.
02:17
And that axial rigidity
over appendicular rigidity
is a common feature of
progressive supranuclear palsy.
02:24
Patients have frequent early
falls, gait difficulty,
they can have insomnia difficulty with
maintaining sleep, personality changes.
02:32
Early Falls is a
hallmark of PSP.
02:35
This is due to early downgaze palsy,
upgaze palsy is not uncommon with aging.
02:40
We see many patients who are neurologically
normal who have vertical upgaze palsy.
02:46
But a downgaze palsy is always abnormal
and should prompt additional workup
and PSP should be
a consideration.
02:53
We also see cognitive
dysfunction in this condition.
02:57
On physical exam, we're looking
to evaluate for a Parkinsonism.
03:00
We're looking for bradykinesia,
rigidity and postural instability,
tremor is uncommon.
03:06
We may see other associated symptoms
of diencephalon dysfunction,
pseudobulbar palsy,
spastic dysarthria, dysphagia.
03:16
Early dysarthria, dysphagia should
prompt workup and consideration of PSP.
03:20
Focal dystonia is not uncommon.
03:23
Bradykinesia and
micrographia can be seen.
03:27
On physical exam, we're also looking
for supranuclear ophthalmoplegia.
03:31
And that's the hallmark of PSP.
03:32
That's a loss of supranuclear
control of eye movements,
a vertical downgaze palsy.
03:38
Blepharospasm, eyelid-opening apraxia
and immobility of the eyes can be seen.
03:45
At the end of the disease patients
may be completely ophthalmoplegic,
unable to move their eyes.
03:52
Other findings that may be seen in
PSP are the "drunken sailor" gait.
03:56
This is a stiff, broad-based gait
with extended knees and trunk
and it results from the
axial rigidity that we see.
04:03
Patients turn by pivoting
quickly on their toes
rather than an "en bloc" turn that
we may see with Parkinson's disease.
04:10
And occasionally,
we can see pyramidal signs in PSP
which would be very,
very uncommon in idiopathic PD.
04:18
The diagnosis of PSP
is made clinically.
04:20
We don't use imaging to
establish this diagnosis.
04:23
But again, late in the disease,
we can see findings on imaging
that are supportive
of this diagnosis.
04:30
Here we're looking at MRI
images on the parasagittal plane
On the right the normal image,
we see a normally large pons and midbrain.
04:38
And on the left, we see an abnormality as
a result of atrophy of that upper midbrain,
slight reduction in the pons and
that beaking of the anterior part
of the midbrain owing
to midbrain atrophy
In terms of treatment,
there is no definitive treatment,
no disease modifying therapy.
04:59
Again with medical therapy, we think
about an initial levadopa challenge.
05:03
Patients often have an
incomplete or inconsistent
or no levadopa response at all.
05:10
Botox can be used
for focal dystonia.